Drug Discovery Platform
The Future of Drug Discovery
Automated Design-Make-Test-Analyse cycle
Retrosynthesis AI
Spaya
Orchestration AI
Generative AI
Makya
Synthesis
Iktos Robotics
Biological testing
Iktos Robotics
Purification & analysis
Iktos Robotics
Benefits
Transforming Drug Discovery with AI and Robotics
Our fully digitized, AI-drive process enables fast progression towards optimal candidates, collecting high quality data at unprecedented speed
Increase Efficiency
Enable six times more parallel projects with the same number of chemists.
Speed Up Drug Discovery
Reduce the timeline to under 24 months.
Our Workflow
Step-by-Step Molecular Journey
Generative AI
The Autonomous Lab transforms drug discovery through a systematic molecular journey. It begins with Makya, our generative AI, which generates optimal molecules in silico.
Retrosynthesis AI
These molecules are then processed by Spaya, our retrosynthesis AI, to identify synthesis routes compatible with our robots.
Orchestration AI
Ilaka, our orchestration AI, takes over to manage the entire workflow, from ordering raw materials to overseeing synthesis campaigns and directing robots to perform the chemistry.
Robot Driven Chemistry
Our Chemspeed platform allow to run 100 reactions per day in parallel across more than 55 different named reactions.
Robot Driven Biology
High-throughput phenotypic assays obtain massive and robust data by observing several thousand of cellular events. Our patented Microtubule Bench technology (MT bench®) industrializes cell testing, a powerful technology to assess drug efficacy directly from inside the cell.
Watch the video of our robots at work
Partnering for Success
Integrated Drug Discovery Collaborations
At Iktos, we collaborate with pharmaceutical and biotech companies to drive innovation in drug discovery. Our Integrated Drug Discovery collaborations leverage our AI and robotics platforms to accelerate the development of new drug candidates.
Enhance your drug discovery projects with our advanced technologies and expert support.
Partner with Iktos
Since our inception in 2016, we have consistently delivered value through over 60+ collaborations with leading pharmaceutical, biotech, and academic institutions. Our highly skilled team is dedicated to pushing the boundaries of AI-driven drug design, making us a trusted partner in your molecular odyssey.
